These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37122239)

  • 1. A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.
    Weiss B; Erritzoe D; Giribaldi B; Nutt DJ; Carhart-Harris RL
    J Psychopharmacol; 2023 Jul; 37(7):717-732. PubMed ID: 37122239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial of Psilocybin versus Escitalopram for Depression.
    Carhart-Harris R; Giribaldi B; Watts R; Baker-Jones M; Murphy-Beiner A; Murphy R; Martell J; Blemings A; Erritzoe D; Nutt DJ
    N Engl J Med; 2021 Apr; 384(15):1402-1411. PubMed ID: 33852780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder.
    Brown ES; Murray M; Carmody TJ; Kennard BD; Hughes CW; Khan DA; Rush AJ
    Ann Allergy Asthma Immunol; 2008 May; 100(5):433-8. PubMed ID: 18517074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation.
    Trivedi MH; Rush AJ; Ibrahim HM; Carmody TJ; Biggs MM; Suppes T; Crismon ML; Shores-Wilson K; Toprac MG; Dennehy EB; Witte B; Kashner TM
    Psychol Med; 2004 Jan; 34(1):73-82. PubMed ID: 14971628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for major depression in private practice.
    Bernstein IH; Wendt B; Nasr SJ; Rush AJ
    J Psychiatr Pract; 2009 Mar; 15(2):87-94. PubMed ID: 19339842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Looking into the effect of multi-item symptom domains on psychometric characteristics of the Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR
    Trujols J; de Diego-Adeliño J; Feliu-Soler A; Iraurgi I; Puigdemont D; Álvarez E; Pérez V; Portella MJ
    Psychiatry Res; 2018 Sep; 267():126-130. PubMed ID: 29890375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Spanish version of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16): a psychometric analysis in a clinical sample.
    Trujols J; de Diego-Adeliño J; Feliu-Soler A; Iraurgi I; Puigdemont D; Alvarez E; Pérez V; Portella MJ
    J Affect Disord; 2014 Dec; 169():189-96. PubMed ID: 25212994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Psychometric Evaluation of the German Version of the Quick Inventory of Depressive Symptomatology (QIDS-SR16) in Outpatients with Depression.
    Roniger A; Späth C; Schweiger U; Klein JP
    Fortschr Neurol Psychiatr; 2015 Dec; 83(12):e17-22. PubMed ID: 26714254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of the QIDS-C16, QIDS-SR16, and the MADRS in an Adult Outpatient Clinical Sample.
    Bernstein IH; Rush AJ; Stegman D; Macleod L; Witte B; Trivedi MH
    CNS Spectr; 2010 Jul; 15(7):458-68. PubMed ID: 20625366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the 16-item Quick Inventory of Depressive Symptomatology: a systematic review and meta-analysis.
    Reilly TJ; MacGillivray SA; Reid IC; Cameron IM
    J Psychiatr Res; 2015 Jan; 60():132-40. PubMed ID: 25300442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties of the Quick Inventory of Depressive Symptomatology (QIDS-SR) in UK primary care.
    Cameron IM; Crawford JR; Cardy AH; du Toit SW; Lawton K; Hay S; Mitchell K; Sharma S; Shivaprasad S; Winning S; Reid IC
    J Psychiatr Res; 2013 May; 47(5):592-8. PubMed ID: 23419617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.
    Weiss B; Ginige I; Shannon L; Giribaldi B; Murphy-Beiner A; Murphy R; Baker-Jones M; Martell J; Nutt DJ; Carhart-Harris RL; Erritzoe D
    Psychol Med; 2024 Jan; 54(1):178-192. PubMed ID: 37264814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.
    Nayak SM; Bari BA; Yaden DB; Spriggs MJ; Rosas FE; Peill JM; Giribaldi B; Erritzoe D; Nutt DJ; Carhart-Harris R
    Psychedelic Med (New Rochelle); 2023 Mar; 1(1):18-26. PubMed ID: 37337526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine.
    McIntyre RS; Lipsitz O; Lui LMW; Rodrigues NB; Gill H; Nasri F; Ling R; Teopiz KM; Ho RC; Subramaniapillai M; Kratiuk K; Mansur RB; Jones BDM; Lee Y; Rosenblat JD
    J Affect Disord; 2021 Nov; 294():592-596. PubMed ID: 34332360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for major and minor depression in a multiethnic sample of Asian primary care patients: a comparison of the nine-item Patient Health Questionnaire (PHQ-9) and the 16-item Quick Inventory of Depressive Symptomatology - Self-Report (QIDS-SR16 ).
    Sung SC; Low CC; Fung DS; Chan YH
    Asia Pac Psychiatry; 2013 Dec; 5(4):249-58. PubMed ID: 24123813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric validation of the 16 Item Quick Inventory of Depressive Symptomatology Self-Report Version (QIDS-SR16) in military veterans with PTSD.
    Surís A; Holder N; Holliday R; Clem M
    J Affect Disord; 2016 Sep; 202():16-22. PubMed ID: 27253212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
    Rush AJ; Trivedi MH; Carmody TJ; Ibrahim HM; Markowitz JC; Keitner GI; Kornstein SG; Arnow B; Klein DN; Manber R; Dunner DL; Gelenberg AJ; Kocsis JH; Nemeroff CB; Fawcett J; Thase ME; Russell JM; Jody DN; Borian FE; Keller MB
    Neuropsychopharmacology; 2005 Feb; 30(2):405-16. PubMed ID: 15578008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric properties of the self-report version of the Quick Inventory of Depressive Symptoms (QIDS-SR₁₆) questionnaire in patients with schizophrenia.
    Lako IM; Wigman JT; Klaassen RM; Slooff CJ; Taxis K; Bartels-Velthuis AA;
    BMC Psychiatry; 2014 Sep; 14():247. PubMed ID: 25178310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.
    Rush AJ; Trivedi MH; Ibrahim HM; Carmody TJ; Arnow B; Klein DN; Markowitz JC; Ninan PT; Kornstein S; Manber R; Thase ME; Kocsis JH; Keller MB
    Biol Psychiatry; 2003 Sep; 54(5):573-83. PubMed ID: 12946886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.